Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA‐B44 supertype
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Human leukocyte antigens (HLA) have long been grouped into supertypes to facilitate peptide‐based immunotherapy. Analysis of several hundreds of peptides presented by all nine antigens of the HLA‐B44 supertype (HLA‐B*18, B*37, B*40, B*41, B*44, B*45, B*47, B*49 and B*50) revealed unique peptide motifs for each of them. Taking all supertype members into consideration only 25 out of 670 natural ligands were found on more than one HLA molecule. Further direct comparisons by two mass spectrometric methods – isotope labeling as well as a label‐free approach – consistently demonstrated only minute overlaps of below 3% between the ligandomes of different HLA antigens. In addition, T cell reactions of healthy donors against immunodominant HLA‐B*44 and HLA‐B*40 epitopes from EBV lacked promiscuous T‐cell recognition within the HLA‐B44 supertype. Taken together, these results challenge the common paradigm of broadly presented epitopes within this supertype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most members of the B44 supertype share a preference for peptides with Glu (E) at anchor position P2 and polar and hydrophobic residues at the C terminus (Fig. 2J) (54, 56).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [54]
Citations
Cites
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
Self-citationBarnstable, C. (1978) · Cell · doi:10.1016/0092-8674(78)90296-9 · Cited by 1,916
IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex
Robinson, J. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg070 · Cited by 810
ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum
Serwold, T., Gonzalez, F., Kim, J., Jacob, R., & Shastri, N. (2002) · Nature · doi:10.1038/nature01074 · Cited by 628
Cao, K., Hollenbach, J., Shi, X., Shi, W., Chopek, M., & Fernández-Viña, M. A. (2001) · Human Immunology · doi:10.1016/s0198-8859(01)00298-1 · Cited by 465
Optimization of the MHC Class I Peptide Cargo Is Dependent on Tapasin
Williams, A. P., Peh, C. A., Purcell, A. W., McCluskey, J., & Elliott, T. (2002) · Immunity · doi:10.1016/s1074-7613(02)00304-7 · Cited by 353
Reits, E., Griekspoor, A., Neijssen, J., Groothuis, T., Jalink, K., van Veelen, P., Janssen, H., Calafat, J., Drijfhout, J. W., & Neefjes, J. (2003) · Immunity · doi:10.1016/s1074-7613(02)00511-3 · Cited by 299
Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs
Sidney, J., Grey, H. M., Kubo, R. T., & Sette, A. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80542-1 · Cited by 260
Macdonald, W. A., Purcell, A. W., Mifsud, N. A., Ely, L. K., Williams, D. S., Chang, L., Gorman, J. J., Clements, C. S., Kjer-Nielsen, L., Koelle, D. M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030066 · Cited by 204
Integrated functional genomics approach for the design of patient-individual antitumor vaccines.
Weinschenk, T., Gouttefangeas, C., Schirle, M., Obermayr, F., Walter, S., Schoor, O., Kurek, R., Loeser, W., Bichler, K., Wernet, D., et al. (2002) · PubMed · Cited by 203
Self-citation
Cited by
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Chowell, D., Morris, L. G. T., Grigg, C. M., Weber, J. K., Samstein, R. M., Makarov, V., Kuo, F., Kendall, S. M., Requena, D., Riaz, N., et al. (2018) · Science · doi:10.1126/science.aao4572 · Cited by 1,142
MHC Class II epitope predictive algorithms
Nielsen, M., Lund, O., Buus, S., & Lundegaard, C. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03268.x · Cited by 236
Chu, Y., Zhang, Y., Wang, Q., Zhang, L., Wang, X., Wang, Y., Salahub, D. R., Xu, Q., Wang, J., Jiang, X., et al. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00459-7 · Cited by 187
Major histocompatibility complex class I binding predictions as a tool in epitope discovery
Lundegaard, C., Lund, O., Buus, S., & Nielsen, M. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03300.x · Cited by 140
Di Marco, M., Schuster, H., Backert, L., Ghosh, M., Rammensee, H.-G., & Stevanović, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700938 · Cited by 111
Self-citationThe human leukocyte antigen-presented ligandome of B lymphocytes
Hassan, C., Kester, M. G. D., de Ru, A. H., Hombrink, P., Drijfhout, J. W., Nijveen, H., Leunissen, J. A. M., Heemskerk, M. H. M., Falkenburg, J. H. F., & van Veelen, P. A. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.024810 · Cited by 98
Distinct Assembly Profiles of HLA-B Molecules
Rizvi, S. M., Salam, N., Geng, J., Qi, Y., Bream, J. H., Duggal, P., Hussain, S. K., Martinson, J. J., Wolinsky, S. M., Carrington, M. N., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301670 · Cited by 112
de Castro, J. A. Ł., Alvarez‐Navarro, C., Brito, A., Guasp, P., Martín‐Esteban, A., & Sanz‐Bravo, A. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.08.005 · Cited by 112
HLA Peptide Length Preferences Control CD8+ T Cell Responses
Rist, M. J., Theodossis, A., Croft, N. P., Neller, M. A., Welland, A., Chen, Z., Sullivan, L. C., Burrows, J. M., Miles, J. J., Brennan, R. M., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300292 · Cited by 71
Mei, S., Li, F., Xiang, D., Ayala, R., Faridi, P., Webb, G. I., Illing, P. T., Rossjohn, J., Akutsu, T., Croft, N. P., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa415 · Cited by 74
Guasp, P., Barnea, E., González‐Escribano, M. F., Jiménez-Reinoso, A., Regueiro, J. R., Admon, A., & de Castro, J. A. Ł. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.789180 · Cited by 64
Guasp, P., Alvarez‐Navarro, C., Gómez-Molina, P., Martín‐Esteban, A., Marcilla, M., Barnea, E., Admon, A., & de Castro, J. A. Ł. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39430 · Cited by 62
HLA class I allele promiscuity revisited
Rao, X., Hoof, I., Costa, A. I. C. A. F., van Baarle, D., & Keşmir, C. (2011) · Immunogenetics · doi:10.1007/s00251-011-0552-6 · Cited by 60
Schellens, I. M. M., Hoof, I., Meiring, H. D., Spijkers, S., Poelen, M. C. M., den Brink, J. A. M. V. G.-V., van der Poel, K., Costa, A. I., van Els, C. A. C. M., van Baarle, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136417 · Cited by 54
Oyarzún, P., Ellis, J. J., González-Galarza, F. F., Jones, A. R., Middleton, D., Mikael Bodén, A., & Kobe, B. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.040 · Cited by 52
Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands
Mester, G., Hoffmann, V., & Stevanović, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0659-9 · Cited by 59
Self-citationLarsen, M. V., Lelic, A., Parsons, R., Nielsen, M., Hoof, I., Lamberth, K., Loeb, M. B., Buus, S., Bramson, J. L., & Lund, O. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012697 · Cited by 45
The MHC Motif Viewer: A Visualization Tool for MHC Binding Motifs
Rapin, N., Hoof, I., Lund, O., & Nielsen, M. (2010) · Current Protocols in Immunology · doi:10.1002/0471142735.im1817s88 · Cited by 41
CD8+ T Cell Responses against TAP-Inhibited Cells Are Readily Detected in the Human Population
Lampen, M. H., Verweij, M. C., Querido, B. J., van der Burg, S. H., Wiertz, E. J. H. J., & van Hall, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001774 · Cited by 38
Marcilla, M., Alpízar, A., Lombardía, M., Ramos-Fernandez, A., Ramos, M., & Albar, J. P. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.034314 · Cited by 33
Badrinath, S., Saunders, P., Huyton, T., Aufderbeck, S., Hiller, O., Blasczyk, R., & Bade‐Doeding, C. (2011) · Haematologica · doi:10.3324/haematol.2011.046037 · Cited by 33
Immunogenetic aspects of erosive osteoarthritis of the hand in patients from northern Italy
Ramonda, R., Musacchio, E., Campana, C., Frigato, M., Frallonardo, P., Barbieri, V., Piccoli, A., Valvason, C., Bronte, V., Zanovello, P., et al. (2010) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2010.507216 · Cited by 31
Schellens, I. M. M., Meiring, H. D., Hoof, I., Spijkers, S., Poelen, M. C. M., den Brink, J. A. M. V. G.-V., Costa, A. I., Vennema, H., Keşmir, C., van Baarle, D., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00546 · Cited by 26
The chimpanzee Mhc-DRB region revisited: Gene content, polymorphism, pseudogenes, and transcripts
de Groot, N. G., Heijmans, C. M. C., de Groot, N., Doxiadis, G. G. M., Otting, Ń., & Bontrop, R. E. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.09.003 · Cited by 28
Vejbaesya, S., Thongpradit, R., Kalayanarooj, S., Luangtrakool, K., Luangtrakool, P., Gibbons, R. V., Srinak, D., Ngammthaworn, S., Apisawes, K., Yoon, I., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv127 · Cited by 29
Seliger, B., Dressler, S. P., Massa, C., Recktenwald, C. V., Altenberend, F., Bukur, J., Marincola, F. M., Wang, E., Stevanović, S., & Lichtenfels, R. (2011) · PROTEOMICS · doi:10.1002/pmic.201000486 · Cited by 24
Self-citationPosition 45 influences the peptide binding motif of HLA-B*44:08
Badrinath, S., Huyton, T., Schumacher, H., Blasczyk, R., & Bade‐Doeding, C. (2011) · Immunogenetics · doi:10.1007/s00251-011-0583-z · Cited by 13
Tedeschi, V., Vitulano, C., Cauli, A., Paladini, F., Piga, M., Mathieu, A., Sorrentino, R., & Fiorillo, M. T. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00031 · Cited by 12
Residue 81 confers a restricted C-terminal peptide binding motif in HLA-B*44:09
Huyton, T., Schumacher, H., Blasczyk, R., & Bade‐Doeding, C. (2012) · Immunogenetics · doi:10.1007/s00251-012-0625-1 · Cited by 9
Lundegaard, C., Buggert, M., Karlsson, A. C., Lund, O., Pérez, C. L., & Nielsen, M. (2010) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/1854776.1854905 · Cited by 8
Low level of HIV-1 evolution after transmission from mother to child
Gijsbers, E. F., van Nuenen, A. C., de la Peña, A. T., Bowles, E. J., Stewart-Jones, G. B. E., Schuitemaker, H., & Kootstra, N. A. (2014) · Scientific Reports · doi:10.1038/srep05079 · Cited by 8
SF3B1K700E Neoantigen Is a CD8+ T-cell Target Shared across Human Myeloid Neoplasms
Biernacki, M. A., Lok, J., Foster, K. A., Cummings, C. C., Busch, S., Black, G., Ray, S., Galvis, L. D. B., Monahan, T. M., Oh, S. T., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0091 · Cited by 7
Zhu, Z., Yang, Q., Li, C., Chen, J., Xiang, M., Chen, M.-M., Yan, M., & Zhu, Z. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7913 · Cited by 8
Allard, S. D., de Goede, A. L., Keersmaecker, B. D., Heirman, C., Lacor, P., Osterhaus, A. D. M. E., Demanet, C., Thielemans, K., Gruters, R. A., & Aerts, J. L. (2012) · Tissue Antigens · doi:10.1111/j.1399-0039.2012.01837.x · Cited by 4
Różańska‐Wróbel, J., Migalska, M., Urbanowicz, A., Grzybek, M., Rego, R. O. M., Bajer, A., Dwużnik-Szarek, D., Alsarraf, M., Behnke‐Borowczyk, J., Behnke, J. M., et al. (2024) · Molecular Ecology · doi:10.1111/mec.17534 · Cited by 7
Ahmed, H. N. T. D. (2014) · Cell Biology Research & Therapy · doi:10.4172/2324-9293.1000111 · Cited by 1
Role of herpes simplex virus 1 protein ICP47 in antigen presentation and pathogenesis
Velusamy, T. (2020) · ANU Open Research (Australian National University) · doi:10.25911/5e6f47d5d81d3 · Cited by 2
A detailed comparison of peptides presented by different HLA class I loci: an in silico approach
Rao, X. (2007) · Utrecht University Repository (Utrecht University)
Cell Biology: Research & Therapy
Tipu, I., & Ahmed, D. (2014)
Identification of tumor antigens for T-cell-mediated cancer immunotherapy
Rammensee, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823901-8.00010-8
Self-citationMünz, C., & Chijioke, O. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735084294.793557461
Metadata
- Authors
- Hillen, N., Mester, G., Lemmel, C., Weinzierl, A. O., Müller, M., Wernet, D., Hennenlotter, J., Stenzl, A., Rammensee, H., & Stevanović, S.
- Affiliations
- University of Tübingen (DE)
- Corresponding author
- Stevanović, Stefan
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2008-11
- Volume
- 38
- Issue
- 11
- Pages
- 2993-3003
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2064890497
- Cited by
- 43
- References
- 31
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 2 · 2020: 2 · 2019: 2 · 2017: 4 · 2016: 2 · 2015: 6 · 2014: 4 · 2013: 3 · 2012: 2
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- HLA-B44, HLA-B40, T cell epitope recognition, immunodominant epitopes, HLA supertypes, isotopic labeling, label-free mass spectrometry
- MeSH terms
- Humans, Ligands, HLA-B Antigens, Antigen Presentation, CD8-Positive T-Lymphocytes, Epitopes, T-Lymphocyte, Amino Acid Motifs, Cell Line, Tumor, HLA-B44 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.